All three major indices are trading up today with the

Dow Jones Industrial Average

(

^DJI

) trading up 32 points (0.2%) at 17,861 as of Friday, May 27, 2016, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,933 issues advancing vs. 985 declining with 172 unchanged.

The Health Care sector currently sits up 0.8% versus the S&P 500, which is up 0.3%. Top gainers within the sector include

Alibaba Group

(

BABA

), up 3.2%,

Incyte

(

INCY

), up 2.0%,

AbbVie

(

ABBV

), up 1.3%,

Abbott Laboratories

(

ABT

), up 1.1% and

Bristol-Myers Squibb Company

(

BMY

), up 0.9%. On the negative front, top decliners within the sector include

Shire

(

SHPG

), down 1.9%, and

Novo Nordisk A/S

(

NVO

), down 0.9%.

TheStreet would like to highlight 3 stocks pushing the sector higher today:

3.

UnitedHealth Group

(

UNH

) is one of the companies pushing the Health Care sector higher today. As of noon trading, UnitedHealth Group is up $1.16 (0.9%) to $134.14 on light volume. Thus far, 687,854 shares of UnitedHealth Group exchanged hands as compared to its average daily volume of 3.1 million shares. The stock has ranged in price between $132.96-$134.53 after having opened the day at $132.98 as compared to the previous trading day's close of $132.98.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. UnitedHealth Group has a market cap of $126.9 billion and is part of the health services industry. Shares are up 13.0% year-to-date as of the close of trading on Thursday. Currently there are 17 analysts who rate UnitedHealth Group a buy, 1 analyst rates it a sell, and 1 rates it a hold.

TheStreet Ratings rates

UnitedHealth Group

as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, growth in earnings per share, increase in net income, solid stock price performance and good cash flow from operations. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full

UnitedHealth Group Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading,

Valeant Pharmaceuticals International

(

VRX

) is up $2.20 (8.2%) to $29.14 on average volume. Thus far, 21.6 million shares of Valeant Pharmaceuticals International exchanged hands as compared to its average daily volume of 34.7 million shares. The stock has ranged in price between $27.84-$29.41 after having opened the day at $28.19 as compared to the previous trading day's close of $26.94.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices worldwide. Valeant Pharmaceuticals International has a market cap of $9.3 billion and is part of the drugs industry. Shares are down 73.5% year-to-date as of the close of trading on Thursday. Currently there are 5 analysts who rate Valeant Pharmaceuticals International a buy, 3 analysts rate it a sell, and 8 rate it a hold.

TheStreet Ratings rates

Valeant Pharmaceuticals International

as a

sell

. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, generally high debt management risk, disappointing return on equity, weak operating cash flow and generally disappointing historical performance in the stock itself. Get the full

Valeant Pharmaceuticals International Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading,

Allergan

(

AGN

) is up $3.10 (1.3%) to $235.46 on light volume. Thus far, 1.7 million shares of Allergan exchanged hands as compared to its average daily volume of 5.2 million shares. The stock has ranged in price between $232.26-$236.48 after having opened the day at $232.99 as compared to the previous trading day's close of $232.36.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Brands, US Medical Aesthetics, International Brands, and Anda Distribution segments. Allergan has a market cap of $90.1 billion and is part of the drugs industry. Shares are down 25.6% year-to-date as of the close of trading on Thursday. Currently there are 13 analysts who rate Allergan a buy, 1 analyst rates it a sell, and 4 rate it a hold.

TheStreet Ratings rates

Allergan

as a

hold

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth and compelling growth in net income. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year. Get the full

Allergan Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care

(

RXD

).